The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study.
Gordana RasicBrendin R Beaulieu-JonesSophie H ChungKelsey S RomatoskiKelly KenzikSing Chau NgJennifer F TsengTeviah E SachsPublished in: Annals of surgical oncology (2023)
For patients diagnosed during COVID, TTI for HCC, while statistically significant, had no clinically significant differences. However, vulnerable patients were more likely to have increased TTI.